Search for: "Pfizer, Inc."
Results 1181 - 1200
of 1,370
Sorted by Relevance
|
Sort by Date
9 Jun 2023, 8:36 am
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
15 Sep 2011, 5:00 am
Apothecon Inc., 431 F. [read post]
8 Dec 2007, 11:00 am
and Netflix. settled patent infringement suit by Constellation covering a system used to display information on Web sites: (IPLaw360), Dell has filed suit against a group of domain registrars, alleging that the companies colluded in infringing Dell's trademarks and counterfeited the Dell brand: (ArsTechnica) Dell pulled into PC tablet patent fight: (IPLaw360), DirectTv held to have willfully infringed FinStar's patent, but obtains compulsory… [read post]
15 Apr 2009, 4:44 am
Philip Morris Inc., 964 F. [read post]
15 Apr 2011, 6:02 am
Target, Inc., 333 F. [read post]
27 Aug 2010, 2:41 pm
Liggett Group, Inc., 683 F. [read post]
23 Jun 2014, 12:57 pm
” Matrixx Initiatives, Inc. v. [read post]
23 Jul 2007, 6:58 am
Pfizer Inc., 381 F. [read post]
23 Jul 2012, 7:58 am
Mazda Canada Inc. is the first case to refer to Lax J. [read post]
21 Jun 2012, 7:40 am
Pfizer, Inc., 724 F. [read post]
25 Jun 2009, 4:29 am
In re Amgen Inc. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
21 Jun 2016, 4:00 am
The Federal Court of Appeal has not squarely addressed the discrete disclosure issue since the SCC arguably “reinvigorated” the debate in Pfizer v Novopharm (“Viagra SCC”)[3], but may address the matter over the next year in Idenix’s pending appeal regarding the hepatitis drug sofosbuvir.[4] There appear to be some inconsistencies in recent FCA decisions. [read post]
14 Jul 2012, 7:08 am
Philip Morris USA, Inc., 449 F. [read post]
4 Sep 2008, 10:07 am
Pfizer, Inc., 2006 WL 2819046 (D.N.J. [read post]
14 Jun 2013, 12:13 pm
Pfizer, 196 F. [read post]
21 Jan 2016, 12:08 pm
Pfizer, Inc.], 153 S.W.3d [758,] 763–64 [(Ky. 2004)]. [read post]
8 Jul 2015, 8:31 am
Inc. v. [read post]
25 Jan 2007, 10:00 pm
Pfizer, 232 F.R.D. 360 (C.D. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
